In yesterday’s Wall Street session, Materialise NV (NASDAQ:MTLS) shares traded at $9.14, up 1.90% from the previous session.
6 analysts cover Materialise NV (NASDAQ:MTLS), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $19.00 and a low of $10.34, we find $15.28. Given the previous closing price of $8.97, this indicates a potential upside of 70.35 percent. MTLS stock price is now -3.34% away from the 50-day moving average and -28.81% away from the 200-day moving average. The market capitalization of the company currently stands at $536.06M.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
The stock has received a hold rating from 2 analysts and a buy rating from 4. Brokers who have rated the stock have averaged $15.72 as their price target over the next twelve months.
With the price target maintained at $20, Bryan Garnier recently Downgraded its rating from Buy to Neutral for Materialise NV (NASDAQ: MTLS). On October 20, 2021, JP Morgan recently initiated its ‘Overweight’ rating on the stock quoting a target price of $28, while ‘Stifel’ rates the stock as ‘Buy’.
A total of 2.37% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in MTLS stock. A new stake in Materialise NV shares was purchased by ENVESTNET ASSET MANAGEMENT INC during the first quarter worth $159,000. CAPITAL IMPACT ADVISORS, LLC invested $56,000 in shares of MTLS during the first quarter. In the first quarter, AQUATIC CAPITAL MANAGEMENT LLC acquired a new stake in Materialise NV valued at approximately $49,000. NEW YORK STATE COMMON RETIREMENT FUND acquired a new stake in MTLS for approximately $14,000. SIGNATUREFD, LLC purchased a new stake in MTLS valued at around $11,000 in the second quarter. In total, there are 82 active investors with 28.70% ownership of the company’s stock.
On Wednesday morning Materialise NV (NASDAQ: MTLS) stock kicked off with the opening price of $9.11. During the past 12 months, Materialise NV has had a low of $8.34 and a high of $23.50. As of last week, the company has a debt-to-equity ratio of 0.35, a current ratio of 2.10, and a quick ratio of 1.90. The fifty day moving average price for MTLS is $9.46 and a two-hundred day moving average price translates $12.84 for the stock.
The latest earnings results from Materialise NV (NASDAQ: MTLS) was released for Jun, 2022. According to the Software – Application Company, earnings per share came in at $0.02, inline with analysts’ expectations of $0.02. This compares to $0.17 EPS in the same period last year. The net profit margin was 3.20% and return on equity was 3.10% for MTLS. The company reported revenue of $56.82 million for the quarter, compared to $60.44 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -5.99 percent. For the current quarter, analysts expect MTLS to generate $55.2M in revenue.
Materialise NV(MTLS) Company Profile
Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company’s Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
